EUVIMEDEUVIMED entdecken
Crossref

Targeting TLR2 agonists as immunomodulators with broad antiviral activity

Nongthombam Boby, Bapi Pahar

Trends in Immunology · 2026-05 · 47 (5) · 354-358

DOI: 10.1016/j.it.2026.03.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Immunology, 2026-05. Verfasst von Nongthombam Boby und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, Karnataka 560012, India. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Antiviral Agents, Virus Diseases, Immunologic Factors. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptor-2 (TLR2) serves as an innate immune sensor that recognizes specific viral proteins, thereby initiating signaling pathways that can either enhance antiviral host defenses or induce pathological inflammatory responses. In this forum, we discuss the role of TLR2 and its agonists in enhancing antiviral and vaccine-induced immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 2Antiviral AgentsVirus DiseasesImmunologic FactorsHumansAnimalsImmunity, InnateToll-Like Receptor AgonistsSignal TransductionInnate Immunity RecognitionHost-Directed TherapyViral Vaccines

Stichwörter der Autor:innen

TLR2adjuvantinnatetherapeuticsvirus

Substanzen

Toll-Like Receptor 2Antiviral AgentsToll-Like Receptor AgonistsImmunologic FactorsViral Vaccines

Autor:innen und Institutionen

  • Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, Karnataka 560012, India.
  • Translational Health Engineering Research Center, Michigan Technological University, Grand Rapids, MI 49503, USA. Electronic address: bpahar@mtu.edu.

Zitieren

APA

Boby, N., & Pahar, B. (2026). Targeting TLR2 agonists as immunomodulators with broad antiviral activity. Trends in Immunology, 47(5), 354-358. https://doi.org/10.1016/j.it.2026.03.003

Vancouver

Boby N, Pahar B. Targeting TLR2 agonists as immunomodulators with broad antiviral activity. Trends in Immunology. 2026;47(5):354-358. doi:10.1016/j.it.2026.03.003

BibTeX
@article{Boby2026,
  author = {Boby, Nongthombam and Pahar, Bapi},
  title = {Targeting TLR2 agonists as immunomodulators with broad antiviral activity},
  journal = {Trends in Immunology},
  year = {2026},
  volume = {47},
  number = {5},
  pages = {354--358},
  doi = {10.1016/j.it.2026.03.003}
}
Kostenlos starten →